Page last updated: 2024-11-03

pyridinolcarbamate and Sleep Initiation and Maintenance Disorders

pyridinolcarbamate has been researched along with Sleep Initiation and Maintenance Disorders in 1 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schettler, G1

Other Studies

1 other study available for pyridinolcarbamate and Sleep Initiation and Maintenance Disorders

ArticleYear
[Undesirable effects of hypolipemic drugs].
    La Clinica terapeutica, 1980, Mar-15, Volume: 92, Issue:5

    Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate;

1980